Abstract
At present, there is no need and no sufficient evidence to support universal screening for vitamin D status. There are four categories of subjects in whom there is no requirement for screening, since a number of studies indicate beneficial effects of vitamin D supplementation; these are represented by children and adolescents, pregnant women, patients taking bone active drugs and subjects with documented hypovitaminosis D. In the remaining subjects, the utilization of adequate questionnaires will target with sufficient sensitivity and specificity those with hypovitaminosis D. These must be first supplemented and, at a later time, serum 25(OH)D assay should be requested to confirm attainment of sufficiency, independently of the threshold chosen. This strategy will cut costs deriving from both widespread use of vitamin D assays and vitamin D supplementation.
Similar content being viewed by others
References
Romagnoli E, Caravella P, Scarnecchia L, Martinez P, Minisola S (1999) Hypovitaminosis D in an Italian population of healthy subjects and hospitalized patients. Br J Nutr 81(2):133–137
Romagnoli E, Pepe J, Piemonte S, Cipriani C, Minisola S (2013) Management of endocrine disease: value and limitations of assessing vitamin D nutritional status and advised levels of vitamin D supplementation. Eur J Endocrinol 169(4):R59–69. https://doi.org/10.1530/EJE-13-0435
Levin GP, Robinson-Cohen C, de Boer IH, Houston DK, Lohman K, Liu Y, Kritchevsky SB, Cauley JA, Tanaka T, Ferrucci L, Bandinelli S, Patel KV, Hagstrom E, Michaelsson K, Melhus H, Wang T, Wolf M, Psaty BM, Siscovick D, Kestenbaum B (2012) Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA 308(18):1898–1905. https://doi.org/10.1001/jama.2012.17304
Minisola S, Cipriani C, Cilli M, Scillitani A, Pepe J (2015) A reappraisal of vitamin D effect on non-skeletal targets and mortality. J Endocrinol Invest 38(11):1239–1241. https://doi.org/10.1007/s40618-015-0387-3
Saponaro F, Marcocci C, Zucchi R (2019) Vitamin D status and cardiovascular outcome. J Endocrinol Invest 42(11):1285–1290. https://doi.org/10.1007/s40618-019-01057-y
Gallo D, Mortara L, Gariboldi MB, Cattaneo SAM, Rosetti S, Gentile L, Noonan DM, Premoli P, Cusini C, Tanda ML, Bartalena L, Piantanida E (2019) Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review. J Endocrinol Invest. https://doi.org/10.1007/s40618-019-01123-5
Hu MJ, Zhang Q, Liang L, Wang SY, Zheng XC, Zhou MM, Yang YW, Zhong Q, Huang F (2018) Association between vitamin D deficiency and risk of thyroid cancer: a case-control study and a meta-analysis. J Endocrinol Invest 41(10):1199–1210. https://doi.org/10.1007/s40618-018-0853-9
Sanders KM, Stuart AL, Williamson EJ, Simpson JA, Kotowicz MA, Young D, Nicholson GC (2010) Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 303(18):1815–1822. https://doi.org/10.1001/jama.2010.594
Minisola S, Ferrone F, Danese V, Cecchetti V, Pepe J, Cipriani C, Colangelo L (2019) Controversies surrounding vitamin D: focus on supplementation and cancer. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph16020189
Minisola S, Pepe J, Donato P, Vigna E, Occhiuto M, Ferrone F, Biamonte F, Cecchetti V, Danese VC, Sonato C, Bi P, Colangelo L, Cipriani C (2019) Replenishment of vitamin D status: theoretical and practical considerations. Hormones 18(1):3–5. https://doi.org/10.1007/s42000-018-0040-6
Minisola S, Colangelo L, Cilli M, Cipriani C, Pepe J, Romagnoli E (2013) Intermittent high doses of vitamin D: a need for further studies? Calcif Tissue Int 92(5):487–488. https://doi.org/10.1007/s00223-013-9714-x
Minisola S, Colangelo L, Cipriani C, Pepe J, Cook DP, Mathieu C (2019) Screening for hypovitaminosis D: cost-effective or not? Eur J Endocrinol 180(3):D1–D7. https://doi.org/10.1530/EJE-18-0977
Bouillon R (2017) Comparative analysis of nutritional guidelines for vitamin D. Nat Rev Endocrinol 13(8):466–479. https://doi.org/10.1038/nrendo.2017.31
Santi M, Janner M, Simonetti GD, Lava SAG (2019) Prescription of vitamin D among Swiss pediatricians. Eur J Pediatr 178(7):1119–1123. https://doi.org/10.1007/s00431-019-03400-0
Uday S, Hogler W (2018) Prevention of rickets and osteomalacia in the UK: political action overdue. Arch Dis Child 103(9):901–906. https://doi.org/10.1136/archdischild-2018-314826
Holick MF (2019) A call to action: pregnant women in-deed require vitamin D supplementation for better health outcomes. J Clin Endocrinol Metab 104(1):13–15. https://doi.org/10.1210/jc.2018-01108
McDonnell SL, Baggerly C, French CB, Baggerly LL, Garland CF, Gorham ED, Lappe JM, Heaney RP (2018) Correction: serum 25-hydroxyvitamin D concentrations %3e/=40 ng/ml are associated with %3e65% lower cancer risk: pooled analysis of randomized trial and prospective cohort study. PLoS ONE 13(7):e0201078. https://doi.org/10.1371/journal.pone.0201078
Santamaria C, Bi WG, Leduc L, Tabatabaei N, Jantchou P, Luo ZC, Audibert F, Nuyt AM, Wei SQ (2018) Prenatal vitamin D status and offspring's growth, adiposity and metabolic health: a systematic review and meta-analysis. Br J Nutr 119(3):310–319. https://doi.org/10.1017/S0007114517003646
Hollis BW, Wagner CL (2013) Vitamin D and pregnancy: skeletal effects, nonskeletal effects, and birth outcomes. Calcif Tissue Int 92(2):128–139. https://doi.org/10.1007/s00223-012-9607-4
Adami S, Giannini S, Bianchi G, Sinigaglia L, Di Munno O, Fiore CE, Minisola S, Rossini M (2009) Vitamin D status and response to treatment in post-menopausal osteoporosis. Osteoporos Int 20(2):239–244. https://doi.org/10.1007/s00198-008-0650-y
Adami S, Isaia G, Luisetto G, Minisola S, Sinigaglia L, Silvestri S, Agnusdei D, Gentilella R, Nuti R (2008) Osteoporosis treatment and fracture incidence: the ICARO longitudinal study. Osteoporos Int 19(8):1219–1223. https://doi.org/10.1007/s00198-008-0566-6
Cairoli E, Eller-Vainicher C, Ulivieri FM, Zhukouskaya VV, Palmieri S, Morelli V, Beck-Peccoz P, Chiodini I (2014) Factors associated with bisphosphonate treatment failure in postmenopausal women with primary osteoporosis. Osteoporos Int 25(4):1401–1410. https://doi.org/10.1007/s00198-014-2619-3
Carnevale V, Manfredi G, Romagnoli E, De Geronimo S, Paglia F, Pepe J, Scillitani A, D'Erasmo E, Minisola S (2004) Vitamin D status in female patients with primary hyperparathyroidism: does it play a role in skeletal damage? Clin Endocrinol 60(1):81–86. https://doi.org/10.1111/j.1365-2265.2004.01946.x
Pepe J, Romagnoli E, Nofroni I, Pacitti MT, De Geronimo S, Letizia C, Tonnarini G, Scarpiello A, D'Erasmo E, Minisola S (2005) Vitamin D status as the major factor determining the circulating levels of parathyroid hormone: a study in normal subjects. Osteoporos Int 16(7):805–812. https://doi.org/10.1007/s00198-004-1757-4
Souberbielle JC, Brazier F, Piketty ML, Cormier C, Minisola S, Cavalier E (2017) How the reference values for serum parathyroid hormone concentration are (or should be) established? J Endocrinol Invest 40(3):241–256. https://doi.org/10.1007/s40618-016-0553-2
Cipriani C, Pepe J, Colangelo L, Minisola S (2018) Vitamin D and secondary hyperparathyroid states. Front Horm Res 50:138–148. https://doi.org/10.1159/000486077
Ferrone F, Pepe J, Danese VC, Fassino V, Cecchetti V, De Lucia F, Biamonte F, Colangelo L, Ferrazza G, Panzini E, Scillitani A, Nieddu L, Blocki F, Rao SD, Minisola S, Cipriani C (2019) The relative influence of serum ionized calcium and 25-hydroxyvitamin D in regulating PTH secretion in healthy subjects. Bone 125:200–206. https://doi.org/10.1016/j.bone.2019.05.029
Bertoldo F, Pancheri S, Zenari S, Boldini S, Giovanazzi B, Zanatta M, Valenti MT, Dalle Carbonare L, Lo Cascio V (2010) Serum 25-hydroxyvitamin D levels modulate the acute-phase response associated with the first nitrogen-containing bisphosphonate infusion. J Bone Miner Res 25(3):447–454. https://doi.org/10.1359/jbmr.090819
Davis RL, Aksornsri A, Papachrisanthou MM (2019) Vitamin D screening variations in children and adolescents: who should be screened? J Pediatr Nurs 45:57–61. https://doi.org/10.1016/j.pedn.2019.02.002
LeBlanc ES, Chou R, Pappas M (2015) Screening for vitamin D deficiency. Ann Intern Med 162(10):738. https://doi.org/10.7326/L15-5094-4
Holick MF (2017) The vitamin D deficiency pandemic: approaches for diagnosis, treatment and prevention. Rev Endocr Metab Disord 18(2):153–165. https://doi.org/10.1007/s11154-017-9424-1
Gannage-Yared MH, Sabbagh R, Chedid R (2018) Relationship between 25 hydroxyvitamin D and lipid profile in Lebanese school children. J Endocrinol Invest 41(9):1043–1049. https://doi.org/10.1007/s40618-018-0840-1
Annweiler C, Kabeshova A, Callens A, Paty ML, Duval GT, Holick MF (2017) Self-administered vitamin D status predictor: older adults are able to use a self-questionnaire for evaluating their vitamin D status. PLoS ONE 12(11):e0186578. https://doi.org/10.1371/journal.pone.0186578
Nabak AC, Johnson RE, Keuler NS, Hansen KE (2014) Can a questionnaire predict vitamin D status in postmenopausal women? Public Health Nutr 17(4):739–746. https://doi.org/10.1017/S1368980013001973
Hanwell HE, Vieth R, Cole DE, Scillitani A, Modoni S, Frusciante V, Ritrovato G, Chiodini I, Minisola S, Carnevale V (2010) Sun exposure questionnaire predicts circulating 25-hydroxyvitamin D concentrations in Caucasian hospital workers in southern Italy. J Steroid Biochem Mol Biol 121(1–2):334–337. https://doi.org/10.1016/j.jsbmb.2010.03.023
Le Moigno JM, Annweiler G, Karras SN, Llewellyn DJ, Riou J, Annweiler C (2019) Clinical identification of older adults with hypovitaminosis D: feasibility, acceptability and accuracy of the ‘vitamin D status diagnosticator’ in primary care. J Steroid Biochem Mol Biol 197:105523. https://doi.org/10.1016/j.jsbmb.2019.105523
Petrilli CM, Henderson J, Keedy JM, Dibble ER, Wei MY, Prussack JK, Greenberg G, Kerr EA (2018) Reducing unnecessary vitamin D screening in an academic health system: what works and when. Am J Med 131(12):1444–1448. https://doi.org/10.1016/j.amjmed.2018.06.025
Scragg RKR (2019) Overview of results from the vitamin D assessment (ViDA) study. J Endocrinol Invest 42(12):1391–1399. https://doi.org/10.1007/s40618-019-01056-z
Manson JE, Cook NR, Lee IM, Christen W, Bassuk SS, Mora S, Gibson H, Gordon D, Copeland T, D'Agostino D, Friedenberg G, Ridge C, Bubes V, Giovannucci EL, Willett WC, Buring JE (2019) Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med 380(1):33–44. https://doi.org/10.1056/NEJMoa1809944
Pittas AG, Dawson-Hughes B, Sheehan P, Ware JH, Knowler WC, Aroda VR, Brodsky I, Ceglia L, Chadha C, Chatterjee R, Desouza C, Dolor R, Foreyt J, Fuss P, Ghazi A, Hsia DS, Johnson KC, Kashyap SR, Kim S, LeBlanc ES, Lewis MR, Liao E, Neff LM, Nelson J, O'Neil P, Park J, Peters A, Phillips LS, Pratley R, Raskin P, Rasouli N, Robbins D, Rosen C, Vickery EM, Staten M (2019) Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med 381(6):520–530. https://doi.org/10.1056/NEJMoa1900906
Binkley N, Lappe J, Singh RJ, Khosla S, Krueger D, Drezner MK, Blank RD (2015) Can vitamin D metabolite measurements facilitate a "treat-to-target" paradigm to guide vitamin D supplementation? Osteoporos Int 26(5):1655–1660. https://doi.org/10.1007/s00198-014-3010-0
Romagnoli E, Mascia ML, Cipriani C, Fassino V, Mazzei F, D'Erasmo E, Carnevale V, Scillitani A, Minisola S (2008) Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly. J Clin Endocrinol Metab 93(8):3015–3020. https://doi.org/10.1210/jc.2008-0350
Cipriani C, Romagnoli E, Scillitani A, Chiodini I, Clerico R, Carnevale V, Mascia ML, Battista C, Viti R, Pileri M, Eller-Vainicher C, Minisola S (2010) Effect of a single oral dose of 600,000 IU of cholecalciferol on serum calciotropic hormones in young subjects with vitamin D deficiency: a prospective intervention study. J Clin Endocrinol Metab 95(10):4771–4777. https://doi.org/10.1210/jc.2010-0502
Cipriani C, Romagnoli E, Pepe J, Russo S, Carlucci L, Piemonte S, Nieddu L, McMahon DJ, Singh R, Minisola S (2013) Long-term bioavailability after a single oral or intramuscular administration of 600,000 IU of ergocalciferol or cholecalciferol: implications for treatment and prophylaxis. J Clin Endocrinol Metab 98(7):2709–2715. https://doi.org/10.1210/jc.2013-1586
American Geriatrics Society Workgroup on Vitamin DSfOA (2014) Recommendations abstracted from the American Geriatrics Society Consensus Statement on vitamin D for Prevention of Falls and Their Consequences. J Am Geriatr Soc 62(1):147–152. https://doi.org/10.1111/jgs.12631
Funding
This work was partly supported by grants from “Sapienza”, Rome University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
SM served as speaker for Abiogen, Amgen, Bruno Farmaceutici, Diasorin, Eli Lilly, Shire, Sandoz, Takeda. He also served in advisory board of Abiogen, Kyowa Kirin, Pfizer, UCB.
Ethical approval
This review article contains no original data using human or animal subjects.
Informed consent
No informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Minisola, S., Colangelo, L., Pepe, J. et al. Vitamin D screening. J Endocrinol Invest 43, 1047–1051 (2020). https://doi.org/10.1007/s40618-020-01220-w
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-020-01220-w